⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 24, 2016Journal of Dermatological Treatment

Stem cell therapy as a novel therapeutic intervention for resistant cases of alopecia areata and androgenetic alopecia

Iman Hamed Elmaadawi Basma Mourad Mohamed Zeinab Abel Samad Ibrahim Said Abdou Yasmina Ahmed El Attar Amira Youssef Maha M. Shamloula Amro Ahmed Taha Hala Gabr Mohamed M. El Afandy Mohamed L. Salem

View at Publisher

Ask AI

Bookmark

Share

Abstract

Autologous BMMCs and FSC seem to be a safe tolerable and effective treatment for the management of both resistant AA and AGA.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Elmaadawi et al. (2016) studied this question.

synapsesocial.com/papers/69d9c3fc9a6164e50fa3d685 https://doi.org/10.1080/09546634.2016.1227419

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Alopecia AreataOriginal Research · 1963 · 415 citations
2Lymphocytes, neuropeptides, and genes involved in alopecia areataOriginal Research · 2007 · 309 citations
3Alopecia areata: medical treatmentsReview · 2015 · 5 citations
4Regenerative medicine in dermatology: biomaterials, tissue engineering, stem cells, gene transfer and beyondReview · 2010 · 123 citations
5Follicular Cell Implantation: An Emerging Cell Therapy for Hair LossOriginal Research · 2005 · 20 citations

More related papers

Stem cells and alopecia: a review of pathogenesis2012
Towards expansion of human hair follicle stem cells in vitro2011
Involvement of the bulge region with decreased expression of hair follicle stem cell markers in senile female cases of alopecia areata2010

More from Journal of Dermatological Treatment

Balancing safety and efficacy in photodynamic therapy for facial port-wine stains in children aged 2-7 years: a prospective controlled study of light-intensity optimizationFri,
5-Aminolevulinic acid-based photodynamic therapy used as a long-term management approach for refractory lichen sclerosusWed,